Newsfile Corp. July 19, 2022·5 min read Calgary, Alberta–(Newsfile Corp. – July 19, 2022) – NurExone Biologic Inc. (TSXV: NRX) (formerly, EnerSpar Corp.) (the “Company” or “NurExone”), a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal injuries and other Central Nervous System (“CNS”) indications, announced the signing of a Material